Advertisement
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
699 dni temu
Honda Cuts EV Sales, Investment Targets As It Shifts Focus
Honda Motor Co., Ltd. announced Tuesday that it is realigning automobile business strategy, with a cut in planned electric vehicle or EV sales ratio, and investment for automobile electrification due to the recent market slowdown. Meanwhile, Honda expects a minimal increase in investment related to Hybrid Electric Vehicle or HEV business.
RTTNews
|
1g 3 minut temu
Bay Street Likely To Open On Cautious Note; Inflation Data In Focus
The Canadian market is likely to see a cautious start Tuesday morning with investors reacting to the nation's consumer price inflation data.
RTTNews
|
3g 32 minut temu
U.S. Dollar Slides Amid U.S. Tariff Uncertainty
The U.S. dollar weakened against other major currencies in the European session on Tuesday, due to fiscal and economic concerns amid uncertainties about U.S. tariffs.
RTTNews
|
3g 59 minut temu
FTSE 100 Moderately Higher As Investors Focus On Earnings
U.K. stocks are up in positive territory on Tuesday, extending gains to a fourth straight session. The focus largely on corporate earnings updates, and the developments on the trade front.
RTTNews
|
4g 46 minut temu
Home Depot Q1 Profit Misses Market, But Sales Beat; Backs Outlook; Stock Up
Home Depot Inc. reported Tuesday weak first-quarter profit below market estimates, while sales grew from last year and beat the Street view with slightly higher comparable sales in the U.S. Further, the home improvement retailer maintained its fiscal 2025 guidance, expecting weak earnings, but higher sales and comparable sales. In the pre-market activity on the NYSE, Home Depot shares were gaining
RTTNews
|
5g 6 minut temu
CAC 40 Modestly Higher
The French market is modestly higher in cautious trade on Tuesday with investors closely following the developments on the geopolitical front.
Tensions between Russia and Ukraine linger despite an announcement from U.S. President Donald Trump that the two nations would soon begin ceasefire negotiations.
RTTNews
|
5g 19 minut temu
U.S. Dollar Falls Against Majors
The U.S. dollar weakened against other major currencies in the European session on Tuesday.
RTTNews
|
5g 23 minut temu
